Amicus Therapeutics, Inc. (FOLD) Ownership

$6.07

$0.14 (-2.25%)
Last update: 04:00 PM EST
Day's range
$6.03
Day's range
$6.2

Amicus Therapeutics, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
WELLINGTON MANAGEMENT GROUP LLP 05/13/2025 29.20 M $238.28 M   2.60% 9.49%
VANGUARD GROUP INC 05/09/2025 29.05 M $237.05 M   -0.71% 9.44%
BLACKROCK, INC. 05/02/2025 27.82 M $227.04 M   -0.30% 9.04%
PERCEPTIVE ADVISORS LLC 05/15/2025 21.46 M $175.15 M   -11.47% 6.98%
AVORO CAPITAL ADVISORS LLC 05/15/2025 20.50 M $167.28 M   -11.54% 6.66%
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC 05/09/2025 14.78 M $120.59 M   -5.25% 4.80%
REDMILE GROUP, LLC 05/15/2025 9.53 M $77.79 M   35.14% 3.10%
STATE STREET CORP 05/15/2025 9.52 M $77.68 M   -8.13% 3.09%
CITADEL ADVISORS LLC 05/15/2025 7.84 M $63.97 M   -4.86% 2.55%
PALO ALTO INVESTORS LP 05/15/2025 7.35 M $59.94 M   -4.14% 2.39%
MACQUARIE GROUP LTD 05/15/2025 6.82 M $55.61 M   2.82% 2.21%
GEODE CAPITAL MANAGEMENT, LLC 05/13/2025 6.76 M $55.20 M   2.31% 2.20%
BANK OF AMERICA CORP /DE/ 05/15/2025 5.60 M $45.69 M   38.70% 1.82%
JPMORGAN CHASE & CO 05/12/2025 4.89 M $39.94 M   -32.16% 1.59%
VESTAL POINT CAPITAL, LP 05/15/2025 4.28 M $34.88 M   27.61% 1.39%
AMERICAN CENTURY COMPANIES INC 05/13/2025 3.90 M $31.82 M   -0.08% 1.27%
05/12/2025 3.52 M $28.74 M   100.00% 1.14%
NORTHERN TRUST CORP 05/13/2025 3.38 M $27.54 M   0.10% 1.10%
MILLENNIUM MANAGEMENT LLC 05/15/2025 3.36 M $27.41 M   635.07% 1.09%
JANUS HENDERSON GROUP PLC 05/15/2025 3.32 M $28.00 M   -2.18% 1.08%
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ 05/02/2025 3.28 M $26.74 M   0.28% 1.06%
POINT72 ASSET MANAGEMENT, L.P. 05/15/2025 2.99 M $24.36 M   100.00% 0.97%
NOVO HOLDINGS A/S 05/15/2025 2.75 M $22.44 M   10.00% 0.89%
GOLDMAN SACHS GROUP INC 05/16/2025 2.70 M $22.06 M   7.74% 0.88%
INVESCO LTD. 05/12/2025 2.66 M $21.72 M   4.14% 0.87%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 05/09/2025 2.49 M $20.33 M   -3.70% 0.81%
HUDSON BAY CAPITAL MANAGEMENT LP 05/14/2025 2.47 M $20.16 M   36.88% 0.80%
BLACKSTONE INC. 05/15/2025 2.47 M $20.13 M   0.00% 0.80%
MORGAN STANLEY 05/15/2025 2.43 M $19.81 M   14.44% 0.79%
D. E. SHAW & CO., INC. 05/15/2025 2.29 M $18.69 M   46.77% 0.74%
ORBIMED ADVISORS LLC 05/15/2025 2.29 M $18.65 M   0.00% 0.74%
GRANITE INVESTMENT PARTNERS, LLC 05/13/2025 2.09 M $17.06 M   25.21% 0.68%
RICE HALL JAMES & ASSOCIATES, LLC 05/01/2025 2.01 M $16.40 M   46.61% 0.65%
ROCK SPRINGS CAPITAL MANAGEMENT LP 05/15/2025 1.91 M $15.58 B   -26.55% 0.62%
PICTET ASSET MANAGEMENT HOLDING SA 05/05/2025 1.63 M $13.72 M   7.29% 0.53%
ABRDN PLC 05/13/2025 1.59 M $12.95 M   14.91% 0.52%
RENAISSANCE TECHNOLOGIES LLC 05/14/2025 1.56 M $12.75 M   -25.92% 0.51%
SQUAREPOINT OPS LLC 05/15/2025 1.54 M $12.57 M   8.66% 0.50%
PANAGORA ASSET MANAGEMENT INC 05/15/2025 1.44 M $11.79 M   0.74% 0.47%
TWO SIGMA INVESTMENTS, LP 05/15/2025 1.39 M $11.36 M   368.25% 0.45%
PROSIGHT MANAGEMENT, LP 05/15/2025 1.38 M $11.26 M   49.93% 0.45%
PRICE T ROWE ASSOCIATES INC /MD/ 05/14/2025 1.28 M $10.47 M   -6.25% 0.42%
UBS ASSET MANAGEMENT AMERICAS INC 05/19/2025 1.07 M $8.75 M   11.87% 0.35%
QUBE RESEARCH & TECHNOLOGIES LTD 05/15/2025 1.07 M $8.74 M   33.30% 0.35%
DEUTSCHE BANK AG\ 05/09/2025 1.04 M $8.48 M   26.38% 0.34%
TWO SIGMA ADVISERS, LP 05/15/2025 1.03 M $8.43 M   822.77% 0.34%
MAN GROUP PLC 05/15/2025 1.02 M $8.31 M   1,736.73% 0.33%
BANK OF NEW YORK MELLON CORP 04/29/2025 978.31 K $7.98 M   -1.13% 0.32%
PRIMECAP MANAGEMENT CO/CA/ 05/09/2025 919.50 K $7.50 M   -1.64% 0.30%
PEREGRINE CAPITAL MANAGEMENT LLC 04/25/2025 910.51 K $7.43 M   3.41% 0.30%

Amicus Therapeutics, Inc. institutional Ownership - FAQ's

During the previous two years, 399 institutional investors and hedge funds held shares of Amicus Therapeutics, Inc.. The most heavily invested institutionals were:

WELLINGTON MANAGEMENT GROUP LLP: 29.2 M

VANGUARD GROUP INC: 29.05 M

BlackRock, Inc.: 27.82 M

PERCEPTIVE ADVISORS LLC: 21.46 M

Avoro Capital Advisors LLC: 20.5 M

WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC: 14.78 M

100.58% of Amicus Therapeutics, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 378.60 M shares in the last 24 months. This purchase volume represents approximately $2.30 B in transactions.